Form 4: Sotera Health Director David E. Wheadon Reports Acquisition of 20,089 Restricted Stock Units

Director David E. Wheadon reports the acquisition of 20,089 Restricted Stock Units (RSUs) in Sotera Health Co on May 24, 2024.

Summary

• On May 24, 2024, David E. Wheadon, a director of Sotera Health Co, acquired 20,089 Restricted Stock Units (RSUs).
• These RSUs were granted under the Sotera Health Company 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock, contingent upon vesting conditions.
• The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to continued service as a non-employee director.
• Following the transaction, Wheadon beneficially owns 55,780 securities, including 20,089 RSUs and 35,691 shares of Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (RSU grant) indicating continued alignment between the director and the company's performance. It's a neutral to slightly positive signal.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and performance.

Future Outlook

The vesting of the RSUs is contingent upon continued service as a non-employee director, suggesting an expectation of continued involvement with the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a grant of equity compensation to a director, which is a common practice.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across publicly traded companies.
• The size and vesting schedule of the RSU grant would need to be compared to similar companies in the healthcare industry to assess its competitiveness.
• Companies like Steris and Medtronic also utilize equity grants as part of their director compensation packages.

Stakeholder Impact

• The RSU grant aligns the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.

Key Dates